Clinical Trial: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07467993) titled 'Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia' on March 09.

Brief Summary: The purpose of this study is to assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Schizophrenia

Intervention: DRUG: GXV813

GXV813 administered orally.

DRUG: Placebo

Placebo administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Disclaimer: Curated by HT Syndication....